Clinical Topics & News

Cervical Cancer Screening

In Europe, the most commonly recommended interval for cervical cancer screening is three years. But that interval can safely be extended to six years for women who test negative for human papillomavirus (HPV), according to the findings of a multinational cohort study with joint database analysis.


 

Recommended Reading

Classifying Cancer Pain
Federal Practitioner
Improving Patient Options for Reducing Postprostatectomy Incontinence
Federal Practitioner
Smoking and Endometrial Cancer
Federal Practitioner
Keeping the Discussion Going About PSA Tests
Federal Practitioner
Hypothyroidism with Sunitnib
Federal Practitioner
IFN for Renal Cell Cancer: Impact of Dose
Federal Practitioner
When to Screen for Postpolypectomy Polyps
Federal Practitioner
Imatinib Five Years Later
Federal Practitioner
Comparing Adverse Effects of Analgesic Strategies for Chronic Cancer Pain
Federal Practitioner
Signs of Cancer: Heed the Alarms
Federal Practitioner